Guidde, an AI digital adoption platform, today announced an oversubscribed $50 million Series B funding round led by PSG Equity, with participation from monday.com and past investors: Norwest, Entrée ...
Mahzi Therapeutics Inc., a clinical-stage biotechnology company developing precision therapies for neurogenetic disorders, today announced that the first patient has been dosed in its Phase 1/2 UNITE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results